Clinical Trials Arena August 19, 2024
Robert Barrie

While Neuralink has implanted its Telepathy device in two patients, other tech companies are further along in their clinical journey.

Neuralink grabbed much of the ‘brain chip’ headlines earlier this month when the company’s founder and owner Elon Musk announced the second successful implant of its device, but the tech startup is far from the only party that has made advancements in the space.

Brain-computer interfaces (BCIs), also called brain-machine interfaces, are chips implanted in brain tissue that take brain signals and translate them into commands. The signals are then relayed to a secondary, external device, which then carries out a specific function. At present, the main application is in the neuromuscular field, meaning paralysed patients can move muscles just...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Medical Devices, Trends
4 Announcements GE HealthCare Made at RSNA 2024
The power of composability: Overcoming field service management challenges in MedTech
3 Innovations Philips Is Showcasing at RSNA 2024
Medtronic-Hexagon Health Lawsuit Highlights the Struggle Between Doctors & Industry
Medicare Competitive Bidding Program Cuts Spending Without Impacting COPD Outcomes

Share This Article